Former Google Employee Charged with Insider Trading Using Internal Data Tesla Launches Full SelfDriving Supervised in China After Years of Delays Facing Intense Local Competition Gold Surpasses 4500 Mark Select Miners Below 45 Attract Market Attention Sacramento Officially Explores Bid for MLB Expansion Team Nvidia Acknowledges Conceding Chinas AI Chip Market to Huawei Amid Export Restrictions The HighStakes Business of Orchid Breeding A DecadeLong Investment with Lucrative Potential CIG Q1 2026 Earnings Earnings Beat Shines Amid Quiet Market Response EVC Q1 2026 Earnings Profitable Quarter Drives Positive Market Reaction BBB Foods Inc TBBB Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Quarter Modular Medical Inc MODD Q3 2025 Earnings Narrowed Loss Per Share Despite Surprise Miss Stock Rises 458 ACLS Q1 2026 Earnings EPS Misses Estimate Marginally Stock Rises 29 MFIN Q1 2026 Earnings Earnings Miss Weighs on Stock Reborn Coffee REBN Edges Lower as Stock Consolidates Near Key Support Level Paysign Inc PAYS Edges Higher as Key Support Holds Pinnacle West Capital PNW Edges Higher as Utility Stock Holds Within Key Range Tectonic Therapeutic TECX Retreats 22 as Stock Tests Key Support Levels Altria Group MO Maintains Stability Near Key Support Level Neelkanth Mishra Sees Scope for Meaningful Rate Cuts Expects Repo Rate to Hit Decade Low LifeMD Q1 2026 Earnings EPS Beats Estimates by 1166 as Stock Rises 119 OFS Credit Company Inc OCCI Holds Near Key Support After Modest Decline ERAS Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Stock Climbs Retractable Technologies Q3 2023 Earnings Loss Per Share of 014 Reported Stock Rises Amid Limited Disclosure FNB Q1 2026 Earnings Slight EPS Miss as Stock Edges Lower AVGO Q1 2026 Earnings EPS Miss and Tepid Stock Response Amid Mixed Signals GOOD Q1 2026 Earnings EPS Beats Estimates by 5686 Stock Declines 163 Public Policy Holding Company Inc PPHC Q4 2025 Earnings EPS Shatters Estimates by 20 as Stock Slips Milestone Pharmaceuticals MIST Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues Pipeline Development